Gilmartin Kathleen A
Known title: DirectorCIK: 0001741732
Gilmartin Kathleen A's purchase track record
How the stock did after each of Gilmartin Kathleen A's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
6
of 6 since December 6, 2021
Stock higher 6 months later
67%
3 months: 67%
Median 6-month return
+14.4%
3 months: +10.3%
Beat the S&P 500
67%
median +11.4% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/20/2025 | USPH | $276K | +26.4% | -7.6% | +13.9% |
| 9/3/2024 | USPH | $172K | +15.7% | -7.2% | +4.5% |
| 11/10/2023 | USPH | $82K | +16.9% | +30.3% | +18.3% |
| 8/24/2022 | USPH | $82K | +4.8% | +22.4% | -3.6% |
| 8/8/2022 | USPH | $55K | -4.8% | +10.0% | -0.7% |
| 12/6/2021 | USPH | $94K | -0.3% | +18.8% | -10.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| USPH | ▲ Buy | Grant | 2,306 | $142K | 5/19/2026 | View on chart |
| USPH | ▲ Buy | Open Market | 4,000 | $276K | 11/20/2025 | View on chart |
| USPH | ▲ Buy | Grant | 1,882 | $0 | 5/20/2025 | View on chart |
| USPH | ▲ Buy | Open Market | 2,000 | $172K | 9/3/2024 | View on chart |
| USPH | ▲ Buy | Grant | 1,424 | $0 | 5/20/2024 | View on chart |
| USPH | ▲ Buy | Open Market | 1,000 | $82K | 11/10/2023 | View on chart |
| USPH | ▲ Buy | Grant | 1,600 | $0 | 5/16/2023 | View on chart |
| USPH | ▲ Buy | Open Market | 1,000 | $82K | 8/24/2022 | View on chart |
| USPH | ▲ Buy | Open Market | 600 | $55K | 8/8/2022 | View on chart |
| USPH | ▲ Buy | Grant | 1,600 | $0 | 5/16/2022 | View on chart |
| USPH | ▲ Buy | Open Market | 1,000 | $94K | 12/6/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
USPH Appoints New CFO and Board Member Amid Earnings Review
U.S. Physical Therapy announced the appointment of a new Chief Financial Officer and a new board member, Myra Davis. These leadership changes are occurring alongside the release of the company's Q2 2026 earnings call transcript. The news has drawn attention to potential shifts in the company's cash flow management and financial narrative.
USPH Appoints New CFO and Board Member Amid Earnings Review. U.S. Physical Therapy announced the appointment of a new Chief Financial Officer and a new board member, Myra Davis. These leadership changes are occurring alongside the release of the company's Q2 2026 earnings call transcript. The news has drawn attention to potential shifts in the company's cash flow management and financial narrative.